Summary
The NICI project’s ambition is to lay the foundations of a new area of research: the study of human biology using non-invasive chemistry imaging. For this, NICI aims to unite two areas of research: metabolomics and magnetic resonance imaging (MRI). Metabolomics studies body functions through the measurement of metabolites; MRI, is able to provide 3D images of the body. By advancing MRI so that it can detect metabolic biomarkers and by discovering powerful new MRI-visible biomarkers, a non-invasive technology can be developed for dynamically mapping biochemical processes in the whole human body.
Vision: This new non-invasive technology for imaging biochemical processes in the human body will open a new and effective window for understanding human biology, diseases and their treatment.
Breakthroughs: I. Methodology for the discovery of discriminative biomarkers and II. Technological platform for full body biochemical imaging.
Novelty: Enabling a paradigm shift from morphologic imaging to biochemical understanding.
Foundational: Establishing the basis for a new research area, the study of human biochemistry using non-invasive biochemical imaging.
High-risk: i) The exact mechanisms of diseases are largely unknown and ii) Measuring specific metabolites is challenging.
Interdisciplinary: Bringing together physicists, biologists, chemists and clinicians.
The NICI project will develop a new methodology for the in vitro discovery of discriminant biomarkers using co-cultured 3D organoids as models for human organs. In addition, the project will develop a measurement platform, integrated with 7T MRI scanners and associated data acquisition approaches to adapt these MRI scanners into 3D biochemical imaging systems. NICI will validate the dynamic 3D chemical imaging approach and its predictive and prognostic value by researching a stratification strategy for patients with liver metastasis of gastrointestinal cancer. (This is one out of many possible applications.)
Vision: This new non-invasive technology for imaging biochemical processes in the human body will open a new and effective window for understanding human biology, diseases and their treatment.
Breakthroughs: I. Methodology for the discovery of discriminative biomarkers and II. Technological platform for full body biochemical imaging.
Novelty: Enabling a paradigm shift from morphologic imaging to biochemical understanding.
Foundational: Establishing the basis for a new research area, the study of human biochemistry using non-invasive biochemical imaging.
High-risk: i) The exact mechanisms of diseases are largely unknown and ii) Measuring specific metabolites is challenging.
Interdisciplinary: Bringing together physicists, biologists, chemists and clinicians.
The NICI project will develop a new methodology for the in vitro discovery of discriminant biomarkers using co-cultured 3D organoids as models for human organs. In addition, the project will develop a measurement platform, integrated with 7T MRI scanners and associated data acquisition approaches to adapt these MRI scanners into 3D biochemical imaging systems. NICI will validate the dynamic 3D chemical imaging approach and its predictive and prognostic value by researching a stratification strategy for patients with liver metastasis of gastrointestinal cancer. (This is one out of many possible applications.)
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/801075 |
| Start date: | 01-06-2018 |
| End date: | 31-08-2023 |
| Total budget - Public funding: | 3 146 973,75 Euro - 3 146 973,00 Euro |
Cordis data
Original description
The NICI project’s ambition is to lay the foundations of a new area of research: the study of human biology using non-invasive chemistry imaging. For this, NICI aims to unite two areas of research: metabolomics and magnetic resonance imaging (MRI). Metabolomics studies body functions through the measurement of metabolites; MRI, is able to provide 3D images of the body. By advancing MRI so that it can detect metabolic biomarkers and by discovering powerful new MRI-visible biomarkers, a non-invasive technology can be developed for dynamically mapping biochemical processes in the whole human body.Vision: This new non-invasive technology for imaging biochemical processes in the human body will open a new and effective window for understanding human biology, diseases and their treatment.
Breakthroughs: I. Methodology for the discovery of discriminative biomarkers and II. Technological platform for full body biochemical imaging.
Novelty: Enabling a paradigm shift from morphologic imaging to biochemical understanding.
Foundational: Establishing the basis for a new research area, the study of human biochemistry using non-invasive biochemical imaging.
High-risk: i) The exact mechanisms of diseases are largely unknown and ii) Measuring specific metabolites is challenging.
Interdisciplinary: Bringing together physicists, biologists, chemists and clinicians.
The NICI project will develop a new methodology for the in vitro discovery of discriminant biomarkers using co-cultured 3D organoids as models for human organs. In addition, the project will develop a measurement platform, integrated with 7T MRI scanners and associated data acquisition approaches to adapt these MRI scanners into 3D biochemical imaging systems. NICI will validate the dynamic 3D chemical imaging approach and its predictive and prognostic value by researching a stratification strategy for patients with liver metastasis of gastrointestinal cancer. (This is one out of many possible applications.)
Status
SIGNEDCall topic
FETOPEN-01-2016-2017Update Date
27-04-2024
Images
No images available.
Geographical location(s)
Search
Organisations
-
| UNIVERSITAIR MEDISCH CENTRUM UTRECHT (Coördinator)
-
| ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
-
| AR BENELUX B.V.
-
| BARTHEL HF-TECHNIK GMBH
-
| GE HEALTHCARE GMBH
-
| GENERAL ELECTRIC DEUTSCHLAND HOLDING GMBH
-
| IMAGO 7 FONDAZIONE DI RICERCA ONLUS
-
| MR COILS BV
-
| NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU
-
| PHILIPS MEDICAL SYSTEMS NEDERLAND BV (PHC)
-
| SIEMENS HEALTHCARE LIMITED
-
| STICHTING VUMC
-
| TESLA DYNAMIC COILS BV
-
| THE UNIVERSITY OF CAMBRIDGE
-
| UNIVERSITA DI PISA